DICLOFENAC EPOLAMINE

DICLOFENAC EPOLAMINE was reported 4269 times

DICLOFENAC EPOLAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE COLD FEELING 4 0.2222
1 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 16 0.0894
2 APPLICATION SITE HAEMATOMA 10 0.0546
3 ACCIDENTAL DEVICE INGESTION 2 0.0455
4 MACROPHAGES INCREASED 3 0.0448
5 APPLICATION SITE BLEEDING 10 0.0405
6 PEPTIC ULCER PERFORATION 10 0.0331
7 CREUTZFELDT-JAKOB DISEASE 9 0.0311
8 MENINGIOMA SURGERY 2 0.0303
9 APPLICATION SITE CELLULITIS 2 0.0299
10 ACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 4 0.0282
11 INTERCOSTAL NEURALGIA 5 0.0281
12 ADMINISTRATION SITE WARMTH 2 0.0244
13 APPLICATION SITE ECZEMA 2 0.0230
14 HYSTEROSALPINGO-OOPHORECTOMY 2 0.0179
15 HYPERPHOSPHATURIA 2 0.0171
16 ENZYME LEVEL ABNORMAL 2 0.0143
17 APPLICATION SITE OEDEMA 4 0.0123
18 OBSTRUCTIVE SLEEP APNOEA SYNDROME 18 0.0123
19 RADICULAR PAIN 4 0.0115
20 EYELID INJURY 2 0.0114
21 MYOGLOBIN BLOOD INCREASED 16 0.0105
22 APPLICATION SITE DERMATITIS 9 0.0096
23 CREST SYNDROME 2 0.0084
24 CHALAZION 5 0.0078
25 POST-TRAUMATIC PAIN 3 0.0066
26 APPLICATION SITE HYPERSENSITIVITY 8 0.0066
27 LACRIMATION DECREASED 3 0.0063
28 PATELLOFEMORAL PAIN SYNDROME 3 0.0058
29 APPLICATION SITE INFLAMMATION 8 0.0058
30 EOSINOPHILIC FASCIITIS 2 0.0058
31 APPLICATION SITE WARMTH 7 0.0055
32 APPLICATION SITE RASH 75 0.0054
33 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 3 0.0053
34 JOINT ANKYLOSIS 3 0.0053
35 BRAIN NATRIURETIC PEPTIDE INCREASED 16 0.0052
36 PLANTAR FASCIITIS 17 0.0051
37 DISCHARGE 7 0.0050
38 DERMO-HYPODERMITIS 3 0.0050
39 MELANOMA RECURRENT 2 0.0048
40 VULVAL DISORDER 3 0.0045
41 CONGENITAL ANOMALY 34 0.0044
42 PRURIGO 4 0.0043
43 APPLICATION SITE ULCER 3 0.0042
44 ANAEMIA MACROCYTIC 9 0.0042
45 ARTHROPOD STING 7 0.0042
46 AMNESTIC DISORDER 2 0.0041
47 GENITAL PAIN 6 0.0041
48 APPLICATION SITE INFECTION 2 0.0039
49 PRESCRIPTION FORM TAMPERING 3 0.0039
50 APPLICATION SITE VESICLES 25 0.0039
51 MANUFACTURING PRODUCT SHIPPING ISSUE 2 0.0037
52 LIGAMENT INJURY 4 0.0035
53 APPLICATION SITE DISCOLOURATION 14 0.0034
54 APPLICATION SITE PAIN 75 0.0034
55 EXOPHTHALMOS 7 0.0033
56 VAGINAL DISORDER 3 0.0031
57 APPLICATION SITE PARAESTHESIA 4 0.0031
58 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
59 APPLICATION SITE EXFOLIATION 12 0.0029
60 APPLICATION SITE BURN 14 0.0028
61 PRODUCT ADHESION ISSUE 100 0.0028
62 TRAUMATIC HAEMATOMA 3 0.0028
63 FIBROCYSTIC BREAST DISEASE 2 0.0027
64 PERSONALITY DISORDER 7 0.0027
65 EXPIRED DRUG ADMINISTERED 13 0.0026
66 POOR QUALITY DRUG ADMINISTERED 17 0.0026
67 APPLICATION SITE SWELLING 13 0.0026
68 APPLICATION SITE DISCHARGE 3 0.0026
69 BODY HEIGHT DECREASED 27 0.0025
70 BARRETT'S OESOPHAGUS 2 0.0025
71 ORAL MUCOSA EROSION 3 0.0024
72 PRODUCT SIZE ISSUE 13 0.0024
73 EXOSTOSIS 22 0.0024
74 APPLICATION SITE PRURITUS 54 0.0024
75 APPLICATION SITE EROSION 3 0.0023
76 ROTATOR CUFF REPAIR 4 0.0023
77 APPLICATION SITE REACTION 16 0.0023
78 TEMPERATURE REGULATION DISORDER 5 0.0022
79 APPLICATION SITE DISCOMFORT 4 0.0022
80 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
81 TRIGGER FINGER 9 0.0022
82 CALCULUS BLADDER 3 0.0022
83 APPLICATION SITE IRRITATION 27 0.0022
84 VASCULAR PURPURA 3 0.0021
85 LIPOATROPHY 2 0.0021
86 APPLICATION SITE ERYTHEMA 55 0.0021
87 POOR QUALITY PRODUCT ADMINISTERED 22 0.0021
88 COMPLEX REGIONAL PAIN SYNDROME 3 0.0020
89 CELL DEATH 4 0.0020
90 BRAIN HERNIATION 6 0.0020
91 GASTRECTOMY 2 0.0020
92 REBOUND ACID HYPERSECRETION 6 0.0020
93 FALSE POSITIVE INVESTIGATION RESULT 2 0.0020
94 PERIPHERAL VENOUS DISEASE 8 0.0020
95 INCREASED UPPER AIRWAY SECRETION 10 0.0019
96 PRE-EXISTING CONDITION IMPROVED 12 0.0019
97 SENSATION OF FOREIGN BODY 16 0.0019
98 APPLICATION SITE SCAB 4 0.0019
99 APPLICATION SITE URTICARIA 4 0.0018
100 PSYCHOMOTOR RETARDATION 5 0.0018
101 VULVOVAGINAL PRURITUS 9 0.0018
102 DISLOCATION OF VERTEBRA 4 0.0018
103 LUMBAR RADICULOPATHY 2 0.0017
104 NEPHROGENIC ANAEMIA 8 0.0017
105 MUCOSAL HAEMORRHAGE 2 0.0017
106 NECK INJURY 5 0.0017
107 INCISION SITE PAIN 2 0.0017
108 ACCIDENTAL EXPOSURE 7 0.0017
109 X-RAY ABNORMAL 3 0.0017
110 SECRETION DISCHARGE 21 0.0017
111 CRANIOCEREBRAL INJURY 5 0.0017
112 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 10 0.0016
113 FRACTURED SACRUM 2 0.0016
114 HAEMORRHAGIC ANAEMIA 7 0.0016
115 NARCOLEPSY 3 0.0016
116 LUPUS VULGARIS 2 0.0016
117 FOREIGN BODY IN THROAT 5 0.0016
118 EXCORIATION 4 0.0016
119 EOSINOPHILIA 27 0.0015
120 BACK DISORDER 25 0.0015
121 BICYTOPENIA 3 0.0015
122 LIP INJURY 2 0.0015
123 EXTRADURAL HAEMATOMA 2 0.0015
124 BRADYPNOEA 4 0.0015
125 BODY MASS INDEX INCREASED 2 0.0015
126 CLUMSINESS 4 0.0015
127 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15 0.0015
128 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 3 0.0014
129 EXPIRED PRODUCT ADMINISTERED 48 0.0014
130 OBSTRUCTIVE AIRWAYS DISORDER 16 0.0014
131 FANCONI SYNDROME 2 0.0014
132 INTERVERTEBRAL DISC DISORDER 6 0.0014
133 JUDGEMENT IMPAIRED 2 0.0014
134 INTENTIONAL DEVICE MISUSE 6 0.0014
135 KNEE DEFORMITY 2 0.0013
136 READING DISORDER 3 0.0013
137 TONGUE OEDEMA 5 0.0013
138 DAYDREAMING 2 0.0013
139 DRUG DIVERSION 8 0.0013
140 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 37 0.0013
141 PURPURA 11 0.0012
142 VITAMIN B12 DEFICIENCY 5 0.0012
143 SPINAL FUSION SURGERY 5 0.0012
144 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 67 0.0012
145 SKIN INJURY 4 0.0012
146 LINEAR IGA DISEASE 2 0.0012
147 CONGESTIVE CARDIOMYOPATHY 5 0.0012
148 GASTRIC DILATATION 2 0.0012
149 HYPERPARATHYROIDISM SECONDARY 3 0.0012
150 CEREBELLAR INFARCTION 2 0.0012
151 LUNG NEOPLASM 5 0.0012
152 FOETAL DEATH 6 0.0012
153 BURSITIS 14 0.0012
154 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
155 EXTREMITY NECROSIS 2 0.0011
156 DERMATITIS CONTACT 13 0.0011
157 PNEUMOTHORAX 18 0.0011
158 LIGAMENT RUPTURE 5 0.0011
159 VULVOVAGINAL DISCOMFORT 5 0.0011
160 BREAST CYST 2 0.0011
161 OVERWEIGHT 6 0.0011
162 SWELLING OF EYELID 7 0.0011
163 APPLICATION SITE HAEMORRHAGE 3 0.0011
164 INTERVERTEBRAL DISC PROTRUSION 24 0.0011
165 ESSENTIAL HYPERTENSION 2 0.0011
166 DRUG SCREEN FALSE POSITIVE 3 0.0011
167 INTERVERTEBRAL DISC DEGENERATION 10 0.0011
168 INTRACRANIAL PRESSURE INCREASED 6 0.0011
169 FIBROMYALGIA 26 0.0011
170 SNORING 4 0.0011
171 DRUG EFFECT INCOMPLETE 38 0.0010
172 BRONCHIECTASIS 7 0.0010
173 BREAST PAIN 11 0.0010
174 GROIN PAIN 9 0.0010
175 SPINAL OSTEOARTHRITIS 9 0.0010
176 JOINT NOISE 2 0.0010
177 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
178 METABOLIC ENCEPHALOPATHY 3 0.0010
179 DEEP VEIN THROMBOSIS POSTOPERATIVE 2 0.0010
180 MIXED LIVER INJURY 3 0.0010
181 EYE INJURY 3 0.0010
182 THERMAL BURN 7 0.0010
183 DERMATITIS BULLOUS 7 0.0010
184 BODY TEMPERATURE FLUCTUATION 2 0.0010
185 APLASTIC ANAEMIA 5 0.0010
186 DRUG ADMINISTERED AT INAPPROPRIATE SITE 10 0.0009
187 SWOLLEN JOINT COUNT INCREASED 3 0.0009
188 LYMPHOCYTOSIS 2 0.0009
189 POOR QUALITY SLEEP 20 0.0009
190 JAW FRACTURE 2 0.0009
191 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0009
192 FACET JOINT SYNDROME 3 0.0009
193 SEASONAL ALLERGY 13 0.0009
194 INTENTIONAL PRODUCT MISUSE 80 0.0009
195 ONYCHOMYCOSIS 4 0.0009
196 DYSGRAPHIA 6 0.0009
197 FOOD ALLERGY 7 0.0009
198 NEURALGIA 22 0.0009
199 CONCUSSION 7 0.0009
200 GASTROINTESTINAL ULCER 2 0.0009
201 CHOLESTATIC LIVER INJURY 2 0.0009
202 CLOSTRIDIAL INFECTION 3 0.0009
203 APPLICATION SITE DRYNESS 3 0.0009
204 LICHENOID KERATOSIS 2 0.0009
205 PUSTULAR PSORIASIS 3 0.0009
206 NERVE COMPRESSION 8 0.0009
207 BREAKTHROUGH PAIN 2 0.0009
208 BONE EROSION 3 0.0008
209 BRADYKINESIA 5 0.0008
210 HEARING IMPAIRED 5 0.0008
211 RASH VESICULAR 4 0.0008
212 PELVIC PAIN 15 0.0008
213 HYPONATRAEMIA 46 0.0008
214 RENAL TUBULAR NECROSIS 8 0.0008
215 DERMAL CYST 2 0.0008
216 BLOOD PRESSURE SYSTOLIC ABNORMAL 2 0.0008
217 CONJUNCTIVITIS 15 0.0008
218 SCOLIOSIS 5 0.0008
219 HYPOAESTHESIA ORAL 12 0.0008
220 BRONCHOSPASM 11 0.0008
221 SPINAL CORD COMPRESSION 3 0.0008
222 EPIGASTRIC DISCOMFORT 3 0.0008
223 TENDERNESS 8 0.0008
224 PETECHIAE 8 0.0008
225 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
226 TINNITUS 35 0.0008
227 EXFOLIATIVE RASH 2 0.0008
228 OSTEOARTHRITIS 32 0.0008
229 NASAL DISORDER 2 0.0008
230 ARTERIOSCLEROSIS 7 0.0007
231 HYPERKALAEMIA 26 0.0007
232 WRONG PRODUCT ADMINISTERED 5 0.0007
233 ULCER HAEMORRHAGE 5 0.0007
234 EAR CONGESTION 2 0.0007
235 BACK INJURY 8 0.0007
236 GASTRIC PERFORATION 2 0.0007
237 CLONUS 2 0.0007
238 FAECALOMA 4 0.0007
239 CYST 9 0.0007
240 NECROSIS 4 0.0007
241 ANAL HAEMORRHAGE 2 0.0007
242 DRUG TOLERANCE DECREASED 2 0.0007
243 CHRONIC KIDNEY DISEASE 54 0.0007
244 SKIN REACTION 10 0.0007
245 NECK MASS 2 0.0007
246 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
247 HAND FRACTURE 5 0.0007
248 HEPATOCELLULAR INJURY 10 0.0007
249 VITAMIN D DECREASED 6 0.0007
250 SHOULDER OPERATION 3 0.0007
251 HEART VALVE INCOMPETENCE 2 0.0007
252 SKIN ATROPHY 4 0.0007
253 MUSCLE STRAIN 6 0.0007
254 URINE OUTPUT DECREASED 6 0.0007
255 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
256 RHEUMATIC FEVER 3 0.0007
257 CREPITATIONS 2 0.0007
258 MYOSITIS 6 0.0007
259 PRODUCT ODOUR ABNORMAL 7 0.0007
260 LUNG ADENOCARCINOMA 2 0.0007
261 CENTRAL VENOUS CATHETERISATION 2 0.0007
262 PEMPHIGOID 5 0.0007
263 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 47 0.0007
264 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
265 SKIN IRRITATION 30 0.0007
266 DIASTOLIC DYSFUNCTION 2 0.0006
267 MENINGIOMA 10 0.0006
268 MUSCULOSKELETAL DISCOMFORT 11 0.0006
269 SPINAL DISORDER 6 0.0006
270 DRUG SCREEN POSITIVE 5 0.0006
271 NERVE INJURY 7 0.0006
272 CORONARY ARTERY DISEASE 19 0.0006
273 SCIATICA 10 0.0006
274 LIMB OPERATION 3 0.0006
275 CHOLESTASIS 12 0.0006
276 HYPERCHOLESTEROLAEMIA 6 0.0006
277 HYPOKINESIA 9 0.0006
278 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 4 0.0006
279 IMPAIRED DRIVING ABILITY 7 0.0006
280 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
281 HYPERAESTHESIA 5 0.0006
282 GASTRITIS 16 0.0006
283 IMMUNE SYSTEM DISORDER 8 0.0006
284 LIGAMENT SPRAIN 6 0.0006
285 FOOT OPERATION 3 0.0006
286 MUSCLE INJURY 5 0.0006
287 MENINGITIS 4 0.0006
288 POOR QUALITY DEVICE USED 6 0.0006
289 JOINT RANGE OF MOTION DECREASED 8 0.0006
290 FACE OEDEMA 10 0.0006
291 BLISTER 33 0.0006
292 WEIGHT LOSS POOR 3 0.0006
293 CARBOHYDRATE ANTIGEN 125 INCREASED 2 0.0006
294 MACULAR DEGENERATION 7 0.0006
295 RASH MACULO-PAPULAR 13 0.0006
296 ECCHYMOSIS 4 0.0006
297 PERIPHERAL VASCULAR DISORDER 3 0.0006
298 CERVICAL VERTEBRAL FRACTURE 2 0.0006
299 LYMPHOEDEMA 4 0.0006
300 ABDOMINAL DISCOMFORT 97 0.0006
301 FORMICATION 4 0.0006
302 JOINT DISLOCATION 6 0.0006
303 LUNG INFILTRATION 5 0.0006
304 ULCER 9 0.0006
305 LACRIMATION INCREASED 17 0.0006
306 FACIAL PAIN 5 0.0006
307 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 4 0.0006
308 DYSPNOEA EXERTIONAL 21 0.0006
309 DECREASED ACTIVITY 6 0.0006
310 ACUTE KIDNEY INJURY 85 0.0006
311 NECK PAIN 31 0.0006
312 BONE LESION 2 0.0006
313 PARAESTHESIA ORAL 8 0.0006
314 END STAGE RENAL DISEASE 10 0.0005
315 BLOOD PHOSPHORUS DECREASED 2 0.0005
316 PRODUCT PHYSICAL ISSUE 11 0.0005
317 MELAENA 12 0.0005
318 GASTRIC ULCER HAEMORRHAGE 3 0.0005
319 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
320 CEREBRAL DISORDER 4 0.0005
321 RASH GENERALISED 14 0.0005
322 AGRANULOCYTOSIS 10 0.0005
323 DUODENAL ULCER PERFORATION 4 0.0005
324 IMMUNODEFICIENCY 8 0.0005
325 RASH PAPULAR 12 0.0005
326 MUSCULOSKELETAL PAIN 28 0.0005
327 HYPOACUSIS 23 0.0005
328 CHRONIC SINUSITIS 2 0.0005
329 ENCEPHALOPATHY 13 0.0005
330 AUTOIMMUNE THYROIDITIS 2 0.0005
331 GASTRIC DISORDER 18 0.0005
332 WRONG TECHNIQUE IN DRUG USAGE PROCESS 19 0.0005
333 COMMUNICATION DISORDER 2 0.0005
334 ARTHRITIS 41 0.0005
335 RHEUMATOID FACTOR POSITIVE 3 0.0005
336 PRESCRIBED OVERDOSE 10 0.0005
337 EYELID OEDEMA 6 0.0005
338 MUSCLE RUPTURE 2 0.0005
339 SPINAL PAIN 6 0.0005
340 HYPERCHLORHYDRIA 3 0.0005
341 COELIAC DISEASE 5 0.0005
342 PRURITUS GENERALISED 11 0.0005
343 KNEE OPERATION 5 0.0005
344 URINARY INCONTINENCE 15 0.0005
345 PLEURISY 3 0.0005
346 RENAL CYST 4 0.0005
347 DRUG INEFFECTIVE 657 0.0005
348 MUSCLE HAEMORRHAGE 2 0.0005
349 TOXIC SKIN ERUPTION 5 0.0005
350 MUSCLE DISORDER 4 0.0005
351 VULVOVAGINAL BURNING SENSATION 3 0.0005
352 INTERNATIONAL NORMALISED RATIO INCREASED 14 0.0005
353 SUBDURAL HAEMATOMA 7 0.0005
354 DEMYELINATION 2 0.0005
355 MENISCUS INJURY 3 0.0005
356 LARYNGEAL OEDEMA 3 0.0005
357 HELICOBACTER INFECTION 5 0.0005
358 ARTHROPATHY 27 0.0005
359 ACUTE CORONARY SYNDROME 4 0.0005
360 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
361 DYSPHONIA 28 0.0005
362 ROAD TRAFFIC ACCIDENT 20 0.0005
363 FOLLICULITIS 5 0.0005
364 HYPOKALAEMIA 22 0.0005
365 LIP OEDEMA 2 0.0005
366 FEBRILE BONE MARROW APLASIA 2 0.0005
367 JOINT INJURY 10 0.0005
368 C-REACTIVE PROTEIN ABNORMAL 3 0.0005
369 IRRITABLE BOWEL SYNDROME 10 0.0005
370 INCOHERENT 3 0.0005
371 HAEMATOMA 12 0.0005
372 DYSURIA 17 0.0005
373 SKIN SWELLING 4 0.0005
374 SOMNAMBULISM 3 0.0005
375 PAIN 280 0.0005
376 ANKYLOSING SPONDYLITIS 6 0.0005
377 TOOTH FRACTURE 5 0.0005
378 IMMUNOSUPPRESSION 4 0.0005
379 CHOLECYSTITIS CHRONIC 3 0.0004
380 IRON DEFICIENCY 2 0.0004
381 LIP DRY 4 0.0004
382 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
383 WHEEZING 26 0.0004
384 EAR DISORDER 2 0.0004
385 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
386 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
387 JOINT SWELLING 52 0.0004
388 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
389 THINKING ABNORMAL 8 0.0004
390 ABDOMINAL PAIN UPPER 88 0.0004
391 FLANK PAIN 4 0.0004
392 RENAL FAILURE ACUTE 18 0.0004
393 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
394 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
395 SLEEP APNOEA SYNDROME 8 0.0004
396 APHAGIA 2 0.0004
397 RENAL FAILURE 55 0.0004
398 RASH PUSTULAR 3 0.0004
399 ORAL DISORDER 3 0.0004
400 EYE PAIN 23 0.0004
401 HEPATOMEGALY 4 0.0004
402 DYSPEPSIA 40 0.0004
403 HYPOPHOSPHATAEMIA 3 0.0004
404 MOVEMENT DISORDER 13 0.0004
405 SINUS DISORDER 8 0.0004
406 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
407 OEDEMA PERIPHERAL 49 0.0004
408 HYPERNATRAEMIA 2 0.0004
409 LOCAL SWELLING 7 0.0004
410 GENERAL SYMPTOM 3 0.0004
411 PEMPHIGUS 5 0.0004
412 DERMATITIS EXFOLIATIVE 2 0.0004
413 SPINAL FRACTURE 8 0.0004
414 CHROMATURIA 9 0.0004
415 COLD SWEAT 7 0.0004
416 BACK PAIN 92 0.0004
417 RECTAL HAEMORRHAGE 17 0.0004
418 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
419 TASTE DISORDER 8 0.0004
420 DISCOMFORT 24 0.0004
421 PALPITATIONS 46 0.0004
422 FEELING ABNORMAL 94 0.0004
423 PRODUCT USE IN UNAPPROVED INDICATION 97 0.0004
424 GOUT 7 0.0004
425 PHARYNGEAL OEDEMA 6 0.0004
426 EAR DISCOMFORT 4 0.0004
427 URINARY RETENTION 13 0.0004
428 GASTROENTERITIS VIRAL 7 0.0004
429 FALL 129 0.0004
430 INFLAMMATION 20 0.0004
431 TENDONITIS 6 0.0004
432 PELVIC FRACTURE 3 0.0004
433 BURNING SENSATION 27 0.0004
434 MALABSORPTION 2 0.0004
435 MULTIPLE ALLERGIES 3 0.0004
436 HYPERSENSITIVITY 71 0.0004
437 HAND DEFORMITY 5 0.0004
438 SCRATCH 4 0.0004
439 HALLUCINATION, VISUAL 8 0.0004
440 FURUNCLE 3 0.0004
441 PRODUCT PRESCRIBING ERROR 9 0.0004
442 HALLUCINATION, AUDITORY 6 0.0004
443 DYSGEUSIA 28 0.0004
444 PAIN IN EXTREMITY 111 0.0004
445 OBESITY 6 0.0004
446 PERIPHERAL SWELLING 58 0.0004
447 NIGHTMARE 13 0.0004
448 HEART RATE INCREASED 37 0.0004
449 SOMNOLENCE 75 0.0004
450 PHOTOPHOBIA 7 0.0004
451 JAUNDICE 10 0.0004
452 FRUSTRATION TOLERANCE DECREASED 3 0.0004
453 RENAL INJURY 11 0.0004
454 FOOT FRACTURE 7 0.0004
455 PRODUCT DISPENSING ERROR 8 0.0004
456 FEELING JITTERY 7 0.0004
457 MIGRAINE 35 0.0004
458 WOUND INFECTION 4 0.0004
459 RASH 159 0.0004
460 COGNITIVE DISORDER 17 0.0004
461 ASTHENOPIA 2 0.0004
462 GASTROINTESTINAL PAIN 4 0.0004
463 DEAFNESS UNILATERAL 2 0.0004
464 FOOT DEFORMITY 4 0.0004
465 BREAST CANCER STAGE II 3 0.0004
466 ERYTHEMA 74 0.0004
467 GAIT INABILITY 12 0.0004
468 PERICARDITIS 6 0.0004
469 HAEMATEMESIS 9 0.0004
470 DISORIENTATION 14 0.0004
471 SCAR 6 0.0004
472 CHOLECYSTECTOMY 4 0.0003
473 GASTROOESOPHAGEAL REFLUX DISEASE 28 0.0003
474 EXERCISE TOLERANCE DECREASED 2 0.0003
475 HYPOAESTHESIA 52 0.0003
476 GASTROINTESTINAL HAEMORRHAGE 29 0.0003
477 CARDIAC MURMUR 3 0.0003
478 GASTROINTESTINAL DISORDER 31 0.0003
479 ORTHOSTATIC HYPOTENSION 6 0.0003
480 VERTIGO 21 0.0003
481 PRURITUS 132 0.0003
482 MUSCLE SPASMS 63 0.0003
483 NAIL DISORDER 3 0.0003
484 GRIP STRENGTH DECREASED 3 0.0003
485 CONFUSIONAL STATE 55 0.0003
486 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
487 PRODUCT QUALITY ISSUE 46 0.0003
488 SKIN HAEMORRHAGE 5 0.0003
489 GALLBLADDER DISORDER 6 0.0003
490 ACCIDENT 4 0.0003
491 RASH ERYTHEMATOUS 16 0.0003
492 GASTROINTESTINAL INFECTION 3 0.0003
493 DRUG EFFECT DECREASED 18 0.0003
494 ANAL INCONTINENCE 3 0.0003
495 SYNOVITIS 6 0.0003
496 RASH PRURITIC 18 0.0003
497 OROPHARYNGEAL DISCOMFORT 3 0.0003
498 INTENTIONAL PRODUCT USE ISSUE 29 0.0003
499 MUSCULOSKELETAL STIFFNESS 29 0.0003
500 ABDOMINAL PAIN 77 0.0003
501 MENTAL IMPAIRMENT 8 0.0003
502 ECONOMIC PROBLEM 5 0.0003
503 PRESYNCOPE 8 0.0003
504 DIZZINESS 164 0.0003
505 RETCHING 7 0.0003
506 MEMORY IMPAIRMENT 45 0.0003
507 IMPAIRED WORK ABILITY 7 0.0003
508 BLOOD PRESSURE INCREASED 50 0.0003
509 MALAISE 143 0.0003
510 DEVICE ADHESION ISSUE 5 0.0003
511 DIVERTICULITIS 9 0.0003
512 GAIT DISTURBANCE 62 0.0003
513 MUSCULOSKELETAL CHEST PAIN 5 0.0003
514 VISUAL IMPAIRMENT 40 0.0003
515 EYE SWELLING 12 0.0003
516 CHEST DISCOMFORT 33 0.0003
517 WOUND 9 0.0003
518 RENAL DISORDER 15 0.0003
519 DRY MOUTH 26 0.0003
520 PSORIATIC ARTHROPATHY 13 0.0003
521 FOETAL EXPOSURE DURING PREGNANCY 26 0.0003
522 BLOOD SODIUM DECREASED 6 0.0003
523 DELIRIUM 11 0.0003
524 BLOOD URINE PRESENT 6 0.0003
525 TOOTH DISORDER 7 0.0003
526 OEDEMA 17 0.0003
527 PULMONARY FIBROSIS 6 0.0003
528 ENTERITIS 2 0.0003
529 DRUG PRESCRIBING ERROR 6 0.0003
530 LOWER LIMB FRACTURE 6 0.0003
531 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
532 SNEEZING 7 0.0003
533 CONTUSION 30 0.0003
534 ROTATOR CUFF SYNDROME 4 0.0003
535 ANAPHYLACTIC SHOCK 8 0.0003
536 HEART RATE IRREGULAR 7 0.0003
537 MUSCLE TIGHTNESS 5 0.0003
538 EAR PAIN 6 0.0003
539 HEPATIC ENZYME INCREASED 21 0.0003
540 AUTOIMMUNE DISORDER 3 0.0003
541 PRODUCT AVAILABILITY ISSUE 7 0.0003
542 PHARYNGEAL SWELLING 3 0.0003
543 BRADYPHRENIA 2 0.0003
544 URTICARIA 51 0.0003
545 INSOMNIA 81 0.0003
546 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
547 DRUG LEVEL INCREASED 5 0.0003
548 HYPOTONIA 3 0.0003
549 SKIN DISORDER 10 0.0003
550 BREAST MASS 2 0.0003
551 ATRIAL FIBRILLATION 29 0.0003
552 HYPERTENSION 63 0.0003
553 THROAT TIGHTNESS 8 0.0003
554 FLUID RETENTION 15 0.0003
555 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
556 MOBILITY DECREASED 21 0.0003
557 RIB FRACTURE 6 0.0003
558 TEMPERATURE INTOLERANCE 3 0.0003
559 JOINT EFFUSION 2 0.0003
560 BALANCE DISORDER 25 0.0003
561 ENCEPHALITIS 2 0.0003
562 LARGE INTESTINE POLYP 2 0.0003
563 HYPERHIDROSIS 37 0.0003
564 INTENTIONAL DRUG MISUSE 6 0.0003
565 DEMENTIA 8 0.0003
566 MASS 4 0.0003
567 CHEST PAIN 53 0.0003
568 BLOOD PRESSURE DECREASED 19 0.0003
569 DEFAECATION URGENCY 2 0.0003
570 KNEE ARTHROPLASTY 6 0.0003
571 MOUTH ULCERATION 6 0.0003
572 INCORRECT DRUG ADMINISTRATION DURATION 8 0.0003
573 HEAD INJURY 9 0.0003
574 HEADACHE 178 0.0003
575 SKIN DISCOLOURATION 13 0.0003
576 HERPES ZOSTER 16 0.0003
577 NAUSEA 220 0.0003
578 ABDOMINAL PAIN LOWER 7 0.0003
579 FAECES DISCOLOURED 6 0.0003
580 BONE DISORDER 5 0.0003
581 DYSSTASIA 8 0.0003
582 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
583 MOUTH HAEMORRHAGE 2 0.0003
584 ANAPHYLACTIC REACTION 15 0.0003
585 LIP SWELLING 9 0.0003
586 ARTHROPOD BITE 2 0.0003
587 DIPLOPIA 7 0.0003
588 FEELING DRUNK 2 0.0003
589 GLOSSODYNIA 6 0.0003
590 EYE PRURITUS 9 0.0003
591 PANCREATITIS ACUTE 6 0.0003
592 JOINT STIFFNESS 7 0.0003
593 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
594 PRODUCT USE ISSUE 50 0.0003
595 DYSARTHRIA 10 0.0003
596 LUNG DISORDER 13 0.0003
597 FLATULENCE 15 0.0003
598 MUSCULAR WEAKNESS 30 0.0003
599 BRADYCARDIA 14 0.0003
600 SCAB 3 0.0003
601 AORTIC ANEURYSM 2 0.0003
602 MUSCULOSKELETAL DISORDER 5 0.0003
603 CONSTIPATION 57 0.0003
604 PARAESTHESIA 41 0.0003
605 FEAR 7 0.0003
606 ANXIETY 74 0.0003
607 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
608 LYMPHOMA 4 0.0003
609 LIMB DISCOMFORT 8 0.0003
610 ANKLE FRACTURE 4 0.0003
611 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
612 PALLOR 7 0.0003
613 CARDIAC DISORDER 24 0.0003
614 SWELLING 24 0.0003
615 BASAL CELL CARCINOMA 4 0.0003
616 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
617 HAEMORRHOIDS 5 0.0003
618 SWOLLEN TONGUE 8 0.0003
619 HAEMATOCHEZIA 14 0.0003
620 DISABILITY 5 0.0003
621 NASAL DISCOMFORT 2 0.0003
622 NASOPHARYNGITIS 46 0.0002
623 NERVOUSNESS 13 0.0002
624 HIP FRACTURE 8 0.0002
625 ECZEMA 13 0.0002
626 VISION BLURRED 34 0.0002
627 RHEUMATOID ARTHRITIS 28 0.0002
628 FEEDING DISORDER 5 0.0002
629 FEELING HOT 15 0.0002
630 LIVER INJURY 6 0.0002
631 ANGINA PECTORIS 7 0.0002
632 MUSCLE SPASTICITY 3 0.0002
633 ABNORMAL FAECES 2 0.0002
634 IMPAIRED HEALING 8 0.0002
635 ESCHERICHIA INFECTION 2 0.0002
636 STAPHYLOCOCCAL INFECTION 8 0.0002
637 GENERALISED OEDEMA 3 0.0002
638 DYSPHAGIA 23 0.0002
639 PHOTOSENSITIVITY REACTION 4 0.0002
640 INJURY 17 0.0002
641 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
642 AGEUSIA 6 0.0002
643 COAGULOPATHY 4 0.0002
644 DRUG INTERACTION 38 0.0002
645 BONE PAIN 14 0.0002
646 DERMATITIS ALLERGIC 3 0.0002
647 DRUG USE DISORDER 2 0.0002
648 ACUTE MYOCARDIAL INFARCTION 7 0.0002
649 BLOOD CHOLESTEROL INCREASED 11 0.0002
650 ARTHRALGIA 98 0.0002
651 INTRAOCULAR PRESSURE INCREASED 3 0.0002
652 HEPATITIS 6 0.0002
653 SINUSITIS 24 0.0002
654 LIVER FUNCTION TEST INCREASED 5 0.0002
655 SKIN ULCER 6 0.0002
656 OCULAR HYPERAEMIA 11 0.0002
657 HIATUS HERNIA 3 0.0002
658 HYSTERECTOMY 2 0.0002
659 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
660 ANAEMIA 44 0.0002
661 AMNESIA 15 0.0002
662 DEAFNESS 6 0.0002
663 MYALGIA 39 0.0002
664 MUCOSAL INFLAMMATION 6 0.0002
665 RASH MACULAR 8 0.0002
666 DRUG ADMINISTRATION ERROR 7 0.0002
667 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
668 HEAD DISCOMFORT 4 0.0002
669 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
670 GENERAL PHYSICAL HEALTH DETERIORATION 26 0.0002
671 ALOPECIA 44 0.0002
672 OFF LABEL USE 196 0.0002
673 PAIN OF SKIN 6 0.0002
674 FREQUENT BOWEL MOVEMENTS 6 0.0002
675 SINUS CONGESTION 3 0.0002
676 LEUKOCYTOSIS 4 0.0002
677 OSTEOMYELITIS 4 0.0002
678 LIMB INJURY 6 0.0002
679 LUPUS-LIKE SYNDROME 2 0.0002
680 RESTLESS LEGS SYNDROME 4 0.0002
681 OSTEOPOROSIS 9 0.0002
682 PERIPHERAL COLDNESS 3 0.0002
683 DIARRHOEA 141 0.0002
684 CELLULITIS 11 0.0002
685 DRUG INTOLERANCE 21 0.0002
686 INCREASED TENDENCY TO BRUISE 2 0.0002
687 NIGHT SWEATS 7 0.0002
688 IRON DEFICIENCY ANAEMIA 2 0.0002
689 BRONCHITIS 16 0.0002
690 FEELING COLD 6 0.0002
691 SWELLING FACE 14 0.0002
692 APHONIA 3 0.0002
693 CARPAL TUNNEL SYNDROME 3 0.0002
694 MIDDLE INSOMNIA 4 0.0002
695 ILL-DEFINED DISORDER 13 0.0002
696 DIARRHOEA HAEMORRHAGIC 2 0.0002
697 CHILLS 25 0.0002
698 BLINDNESS UNILATERAL 3 0.0002
699 LACERATION 2 0.0002
700 ASTHMA 24 0.0002
701 DYSPNOEA 120 0.0002
702 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 15 0.0002
703 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
704 GASTRIC ULCER 4 0.0002
705 VIRAL INFECTION 7 0.0002
706 SPEECH DISORDER 11 0.0002
707 DEHYDRATION 28 0.0002
708 AFFECT LABILITY 2 0.0002
709 MYELODYSPLASTIC SYNDROME 3 0.0002
710 FLUSHING 21 0.0002
711 INFLUENZA LIKE ILLNESS 17 0.0002
712 OROPHARYNGEAL PAIN 19 0.0002
713 CHOKING 4 0.0002
714 AGITATION 15 0.0002
715 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 41 0.0002
716 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
717 ASTHENIA 76 0.0002
718 HAEMATOCRIT DECREASED 4 0.0002
719 CATARACT 12 0.0002
720 BLADDER DISORDER 2 0.0002
721 WEIGHT INCREASED 45 0.0002
722 UPPER LIMB FRACTURE 4 0.0002
723 RESPIRATORY DISORDER 6 0.0002
724 SLEEP DISORDER 14 0.0002
725 DYSKINESIA 8 0.0002
726 THROMBOCYTOPENIA 22 0.0002
727 HIP ARTHROPLASTY 3 0.0002
728 UNRESPONSIVE TO STIMULI 5 0.0002
729 TREATMENT FAILURE 16 0.0002
730 TREMOR 32 0.0002
731 C-REACTIVE PROTEIN INCREASED 7 0.0002
732 ABDOMINAL DISTENSION 20 0.0002
733 VOMITING 90 0.0002
734 BRAIN FOG 3 0.0002
735 SEDATION 5 0.0002
736 DERMATITIS 4 0.0002
737 MULTIPLE SCLEROSIS 9 0.0002
738 COLITIS 7 0.0002
739 DEPRESSION 42 0.0002
740 BIPOLAR DISORDER 2 0.0002
741 PRODUCT PRESCRIBING ISSUE 4 0.0002
742 IRRITABILITY 11 0.0002
743 SKIN LESION 5 0.0002
744 SKIN BURNING SENSATION 13 0.0002
745 MENTAL STATUS CHANGES 5 0.0002
746 FATIGUE 140 0.0002
747 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
748 HAEMOPTYSIS 5 0.0002
749 WEIGHT DECREASED 50 0.0002
750 MALNUTRITION 2 0.0002
751 ORAL PAIN 4 0.0002
752 INTESTINAL PERFORATION 2 0.0002
753 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
754 EYE INFECTION 2 0.0002
755 MITRAL VALVE INCOMPETENCE 2 0.0002
756 HAEMATURIA 6 0.0002
757 MICTURITION URGENCY 2 0.0002
758 ILLNESS 18 0.0002
759 HYPERSOMNIA 5 0.0002
760 CONDITION AGGRAVATED 53 0.0002
761 LETHARGY 10 0.0002
762 GASTRIC HAEMORRHAGE 2 0.0002
763 EYE IRRITATION 10 0.0002
764 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
765 MUSCLE TWITCHING 4 0.0002
766 INFECTION 25 0.0002
767 UNEVALUABLE EVENT 13 0.0002
768 SYRINGE ISSUE 3 0.0002
769 NO ADVERSE EVENT 31 0.0002
770 INFLUENZA 19 0.0002
771 DEPRESSED MOOD 9 0.0002
772 RHINORRHOEA 11 0.0002
773 NASAL CONGESTION 10 0.0002
774 BACTERAEMIA 2 0.0002
775 MYOCLONUS 2 0.0002
776 ADVERSE DRUG REACTION 15 0.0002
777 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
778 TOOTHACHE 3 0.0002
779 HEPATITIS C 2 0.0002
780 CRYING 6 0.0002
781 ADRENAL INSUFFICIENCY 2 0.0002
782 PYREXIA 57 0.0002
783 URINARY TRACT INFECTION 28 0.0002
784 ACCIDENTAL OVERDOSE 6 0.0002
785 RESTLESSNESS 6 0.0002
786 DECREASED APPETITE 38 0.0002
787 CARDIOMEGALY 2 0.0002
788 OSTEONECROSIS OF JAW 4 0.0002
789 FEMUR FRACTURE 5 0.0002
790 HEPATIC STEATOSIS 3 0.0002
791 MENTAL DISORDER 7 0.0002
792 PSORIASIS 21 0.0002
793 EPISTAXIS 12 0.0002
794 INJECTION SITE DISCOLOURATION 2 0.0002
795 HEPATIC CIRRHOSIS 3 0.0002
796 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
797 PROTEINURIA 3 0.0002
798 NEUROPATHY PERIPHERAL 15 0.0002
799 TACHYCARDIA 14 0.0002
800 COUGH 44 0.0002
801 HEPATIC CYTOLYSIS 2 0.0002
802 HYPOPHAGIA 4 0.0002
803 METABOLIC ACIDOSIS 5 0.0002
804 THROAT IRRITATION 7 0.0002
805 ACUTE RESPIRATORY FAILURE 3 0.0002
806 ANOREXIA 2 0.0002
807 DYSTONIA 3 0.0002
808 LACTIC ACIDOSIS 5 0.0002
809 DEEP VEIN THROMBOSIS 10 0.0002
810 KIDNEY INFECTION 3 0.0002
811 ANHEDONIA 4 0.0002
812 BEDRIDDEN 2 0.0002
813 BLOOD PRESSURE ABNORMAL 3 0.0002
814 INFUSION RELATED REACTION 10 0.0002
815 DYSMENORRHOEA 2 0.0002
816 ADVERSE REACTION 2 0.0002
817 EAR INFECTION 4 0.0002
818 EYE HAEMORRHAGE 2 0.0001
819 NEOPLASM MALIGNANT 10 0.0001
820 THROMBOSIS 12 0.0001
821 STOMATITIS 9 0.0001
822 ANGER 5 0.0001
823 BONE MARROW FAILURE 3 0.0001
824 BLINDNESS 6 0.0001
825 IMPAIRED GASTRIC EMPTYING 2 0.0001
826 CORONARY ARTERY OCCLUSION 2 0.0001
827 RESPIRATORY ARREST 4 0.0001
828 TOOTH LOSS 3 0.0001
829 HYPOGLYCAEMIA 7 0.0001
830 DIABETES MELLITUS 11 0.0001
831 POLLAKIURIA 6 0.0001
832 HYPOMAGNESAEMIA 2 0.0001
833 HUNGER 2 0.0001
834 WITHDRAWAL SYNDROME 6 0.0001
835 SKIN EXFOLIATION 12 0.0001
836 HYPOXIA 5 0.0001
837 LYMPHADENOPATHY 5 0.0001
838 PAIN IN JAW 4 0.0001
839 DIALYSIS 2 0.0001
840 HYPOTENSION 28 0.0001
841 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
842 BLOOD GLUCOSE INCREASED 26 0.0001
843 PRODUCT DOSE OMISSION 9 0.0001
844 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
845 PANIC ATTACK 5 0.0001
846 RESPIRATORY FAILURE 10 0.0001
847 GASTROENTERITIS 2 0.0001
848 PULMONARY EMBOLISM 13 0.0001
849 LIVER DISORDER 6 0.0001
850 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
851 HAEMORRHAGE INTRACRANIAL 2 0.0001
852 PANCREATITIS 7 0.0001
853 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
854 RENAL IMPAIRMENT 11 0.0001
855 NEPHROLITHIASIS 6 0.0001
856 CEREBROVASCULAR ACCIDENT 22 0.0001
857 EMOTIONAL DISORDER 4 0.0001
858 DELUSION 2 0.0001
859 DRUG-INDUCED LIVER INJURY 4 0.0001
860 ABSCESS 2 0.0001
861 HYPOTHYROIDISM 4 0.0001
862 BLOOD PRESSURE FLUCTUATION 3 0.0001
863 CARDIAC FAILURE 10 0.0001
864 INTERSTITIAL LUNG DISEASE 6 0.0001
865 CHOLELITHIASIS 4 0.0001
866 OSTEONECROSIS 4 0.0001
867 ABASIA 3 0.0001
868 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
869 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
870 FUNGAL INFECTION 4 0.0001
871 LEUKOPENIA 6 0.0001
872 HALLUCINATION 9 0.0001
873 HOT FLUSH 9 0.0001
874 ADVERSE EVENT 11 0.0001
875 PRODUCT COMPLAINT 3 0.0001
876 HEMIPARESIS 2 0.0001
877 PNEUMONIA 38 0.0001
878 LOSS OF CONSCIOUSNESS 15 0.0001
879 THERAPEUTIC RESPONSE DECREASED 7 0.0001
880 DEVICE USE ISSUE 2 0.0001
881 ANGIOEDEMA 5 0.0001
882 DRUG ERUPTION 2 0.0001
883 DRY SKIN 15 0.0001
884 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
885 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
886 PNEUMONITIS 3 0.0001
887 TREATMENT NONCOMPLIANCE 6 0.0001
888 INTENTIONAL OVERDOSE 7 0.0001
889 PROCEDURAL PAIN 3 0.0001
890 MEDICATION ERROR 6 0.0001
891 BACTERIAL INFECTION 2 0.0001
892 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
893 FRACTURE 2 0.0001
894 COMA 5 0.0001
895 INCREASED APPETITE 2 0.0001
896 PRODUCT SUBSTITUTION ISSUE 6 0.0001
897 GLAUCOMA 2 0.0001
898 LIVER FUNCTION TEST ABNORMAL 3 0.0001
899 LABORATORY TEST ABNORMAL 3 0.0001
900 DRY EYE 5 0.0001
901 CARDIAC FAILURE CONGESTIVE 8 0.0001
902 FULL BLOOD COUNT DECREASED 2 0.0001
903 EPILEPSY 3 0.0001
904 BODY TEMPERATURE INCREASED 2 0.0001
905 HAEMOGLOBIN DECREASED 10 0.0001
906 EXPOSURE DURING PREGNANCY 6 0.0001
907 CYSTITIS 3 0.0001
908 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
909 MOOD SWINGS 3 0.0001
910 DISTURBANCE IN ATTENTION 5 0.0001
911 OVERDOSE 20 0.0001
912 BLOOD CREATININE INCREASED 6 0.0001
913 MYOCARDIAL INFARCTION 16 0.0001
914 EYE DISORDER 3 0.0001
915 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
916 SYNCOPE 9 0.0001
917 TYPE 2 DIABETES MELLITUS 3 0.0001
918 DRUG DEPENDENCE 14 0.0001
919 HAEMORRHAGE 9 0.0001
920 HEART RATE DECREASED 3 0.0001
921 ARRHYTHMIA 4 0.0001
922 DRUG ABUSE 7 0.0001
923 DISEASE RECURRENCE 4 0.0001
924 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
925 LOCALISED INFECTION 2 0.0001
926 HYPERGLYCAEMIA 3 0.0001
927 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
928 EXTRAPYRAMIDAL DISORDER 2 0.0001
929 INTESTINAL OBSTRUCTION 3 0.0001
930 CARDIOVASCULAR DISORDER 2 0.0001
931 SUICIDAL IDEATION 7 0.0001
932 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
933 ABNORMAL BEHAVIOUR 3 0.0001
934 ABORTION SPONTANEOUS 3 0.0001
935 INJECTION SITE PRURITUS 5 0.0001
936 BLOOD BILIRUBIN INCREASED 2 0.0001
937 INJECTION SITE REACTION 5 0.0001
938 DRUG DOSE OMISSION 12 0.0001
939 COMPLETED SUICIDE 6 0.0001
940 RHABDOMYOLYSIS 3 0.0001
941 TOXICITY TO VARIOUS AGENTS 12 0.0001
942 INCORRECT DOSE ADMINISTERED 16 0.0001
943 CONVULSION 4 0.0001
944 SEIZURE 8 0.0001
945 VAGINAL HAEMORRHAGE 3 0.0001
946 SEPTIC SHOCK 3 0.0001
947 COVID-19 12 0.0001
948 SURGERY 4 0.0001
949 COLITIS ULCERATIVE 3 0.0001
950 BLOOD POTASSIUM DECREASED 2 0.0001
951 HEPATIC FAILURE 2 0.0001
952 APHASIA 2 0.0001
953 PLEURAL EFFUSION 4 0.0001
954 PRODUCTIVE COUGH 3 0.0001
955 SEPSIS 7 0.0001
956 AGGRESSION 3 0.0001
957 NEUTROPENIA 8 0.0001
958 THERAPY CESSATION 3 0.0001
959 EMOTIONAL DISTRESS 7 0.0001
960 PRODUCT DOSE OMISSION ISSUE 17 0.0001
961 DEVICE USE ERROR 2 0.0001
962 THERAPY INTERRUPTED 4 0.0001
963 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
964 CEREBRAL HAEMORRHAGE 2 0.0001
965 INJECTION SITE MASS 2 0.0001
966 HEPATIC FUNCTION ABNORMAL 2 0.0001
967 INJECTION SITE BRUISING 4 0.0001
968 EXTRA DOSE ADMINISTERED 2 0.0000
969 DEVICE BREAKAGE 2 0.0000
970 LUNG NEOPLASM MALIGNANT 2 0.0000
971 CARDIO-RESPIRATORY ARREST 2 0.0000
972 DEVICE DISLOCATION 2 0.0000
973 INJECTION SITE PAIN 14 0.0000
974 DEVICE ISSUE 4 0.0000
975 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
976 DEATH 36 0.0000
977 BLOOD GLUCOSE DECREASED 2 0.0000
978 UNDERDOSE 3 0.0000
979 PROSTATE CANCER 3 0.0000
980 CARDIAC ARREST 3 0.0000
981 DRUG WITHDRAWAL SYNDROME 3 0.0000
982 HOSPITALISATION 5 0.0000
983 INJECTION SITE ERYTHEMA 4 0.0000
984 DEVICE MALFUNCTION 2 0.0000
985 PLATELET COUNT DECREASED 3 0.0000
986 INJECTION SITE SWELLING 2 0.0000
987 DISEASE PROGRESSION 3 0.0000
988 BREAST CANCER 2 0.0000
989 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000